Live Feeds
● TRACKER Updated 29d ago · 55 sources tracked

Towards Conversational AI for Disease Management

UPMC is expanding an AI-native clinical services model for transitional care management to 18 hospitals this fall. The program, which utilizes ThinkAndor from Andor Health, began at UPMC Jameson in New Castle, Pennsylvania. Following an expansion to 10 hospitals, one additional site will launch on September 1 and seven more will follow on September 22. This rollout represents a shift toward integrating AI directly into clinical workflows to manage patient transitions across a health system.

🎙️

Listen to Live Briefing

Real-time synthesized voice briefing · Live Feeds Desk

⏱ ~2 min
Speed:
RSS Source map (55)
⚡ Key Developments & Real-Time Context
Text size:
  • ✓ UPMC is expanding an AI-native clinical services model in transitional care management to 18 hospitals this fall.
  • ✓ The AI program runs on ThinkAndor from Andor Health.
  • ✓ The initiative started at UPMC Jameson in New Castle, Pennsylvania.
  • ✓ One hospital will launch the service on September 1 and seven more will launch on September 22.
🛡️ Source Corroboration: 55 independent reporting domains (100% confidence) ⏱ Read time: ~2 min

What changed

UPMC is deploying ThinkAndor AI-native clinical services across 18 hospitals by September 22.

Live updates

  1. UPMC Scales AI-Native Clinical Services to 18 Hospitals

    UPMC is expanding an AI-native clinical services model for transitional care management to 18 hospitals this fall. The program, which utilizes ThinkAndor from Andor Health, began at UPMC Jameson in New Castle, Pennsylvania. Following an expansion to 10 hospitals, one additional site will launch on September 1 and seven more will follow on September 22. This rollout represents a shift toward integrating AI directly into clinical workflows to manage patient transitions across a health system.

    Why it matters

    Previous reports highlighted a tension between AI's potential for personalized care and public skepticism regarding chatbot efficacy. This expansion moves AI from research and data analysis into active clinical service delivery. It tests whether AI-native models can improve patient outcomes in real-world hospital settings.

    What is confirmed

    • UPMC is expanding an AI-native clinical services model in transitional care management to 18 hospitals this fall.
    • The AI program runs on ThinkAndor from Andor Health.
    • The initiative started at UPMC Jameson in New Castle, Pennsylvania.
    • One hospital will launch the service on September 1 and seven more will launch on September 22.

    What to watch next

    • Clinical outcome data from the 18 UPMC hospitals following the September rollout
    • Updates on the Jharkhand AI Policy 2026 regarding citizen outcomes
    Sources used for this update (9)
    1. finance.yahoo.com — Meet The EMBA Class Of Entrepreneurs: Executives Today, Founders Tomorrow
    2. www.dqindia.com — Jharkhand AI Policy 2026: Pooja Singhal on AI Governance, Infrastructure and Inclusion
    3. oncodaily.com — ASCO 2026 Guideline: A Risk-Adapted Framework for Early HR-Positive, HER2-Negative Breast Cancer
    4. www.frontiersin.org — Artificial Intelligence in Women’s Reproductive and Maternal Health: Advancing Prediction, Prevention, and Personalized Care
    5. finance.yahoo.com — UPMC Expands AI-Native Clinical Services to 18 Hospitals This Fall
    6. www.ad-hoc-news.de — Sanofi stock benefits from new Covid vaccine approvals and growing vaccine demand
    7. www.thedailybeast.com — ’90s Star Dies at 52 After Meningitis Battle
    8. www.jcnnewswire.com — Merdeka Gold Delivers Strong Q2 Production Ramp-Up as Pani Gold Mine Advances Toward Full-year Growth
    9. www.jcnnewswire.com — Redion Holiday Barometer 2026: Singapore Sets a Global Benchmark for the Most Insured Travelers as Expectations for Travel Support Rise
    confidence 100%

  2. AI Integration in Mental Health and Chronic Disease Management

    AI is moving toward personalized care through large-scale data analysis, though public opinion remains divided. Researchers developed a platform using 1 million Reddit threads to identify mental health concerns and accelerate treatment. Meanwhile, a Pew Research study indicates more Americans believe chatbots harm rather than help those seeking support for stress, depression, or loneliness. Other initiatives, such as Project Remission, are attempting to shift chronic disease management toward lifestyle-based reversibility, though critics argue this approach ignores systemic economic and environmental drivers of illness.

    Why it matters

    Conversational AI aims to reduce physician workloads and improve patient outcomes. This shift follows earlier implementations like LymeLess Health's Ella for tick-borne diseases. The current tension lies between technical capabilities and public trust in AI-driven social support.

    What is confirmed

    • A platform utilizing 1 million health-related Reddit threads can identify mental health concerns to personalize care.
    • More Americans believe chatbots hurt people using them for social and mental health support than help them.

    Still unconfirmed

    • Project Remission claims chronic disease is potentially reversible through lifestyle changes.
    • Project Remission may ignore economic, environmental, and public health policies that shape individual choices.

    What to watch next

    • Clinical results from the Reddit-based mental health AI platform
    • Public opinion shifts regarding AI for loneliness and depression
    Sources used for this update (5)
    1. www.devdiscourse.com — Agriculture’s Next AI Leap Could Change Who Makes the Decisions
    2. www.pewresearch.org — Do Americans think chatbots help or hurt people using them for loneliness, depression or stress?
    3. www.acsh.org — The Privilege Test: Why Project Remission Misses the Mark on Chronic Disease
    4. medicalxpress.com — Research shows AI can fast track mental health care
    5. www.mtexpress.com — ‘It’s a solvable problem’
    confidence 90%

  3. AI in Disease Management: Conversational Tools on the Rise

    Conversational AI is increasingly being used in disease management, with tools like LymeLess Health's Ella assisting patients with Lyme and tick-borne diseases. The use of AI in healthcare is expanding, with applications in mental health support, clinical trials, and predictive tools. This trend is driven by the potential for AI to improve patient outcomes, reduce administrative burdens on physicians, and enhance the overall efficiency of healthcare services.

    Why it matters

    The integration of AI in healthcare is part of a broader trend of technological advancements in the industry. The use of AI in disease management is particularly significant, as it has the potential to improve patient outcomes and reduce the burden on healthcare systems. However, there are also concerns about the risks associated with AI in healthcare, including data privacy and the need for human oversight in life-altering medical decisions.

    What is confirmed

    • Over 40 million people worldwide use AI therapy apps every month.
    • The market for mental health apps is projected to hit $17.5 billion by 2028.
    • Conversational agents are being used to take on scheduling, intake, and follow-ups in clinics.

    Still unconfirmed

    • AI health trends 2026 will reshape the medical future with a seismic shift in healthcare.

    What to watch next

    • Regulatory developments on AI integration in healthcare
    • Studies on the efficacy of AI therapy apps
    • Adoption rates of conversational AI platforms in clinics
    Sources used for this update (5)
    1. www.nzherald.co.nz — Smart tech & AI are reaching into every aspect of our healthcare - is the risk worth the reward?
    2. www.thetechedvocate.org — The Silent Battle: Why Millions Are Ditching Traditional Therapy for AI
    3. www.thetechedvocate.org — Jaw-Dropping Shift: How AI Health Trends 2026 Will Reshape Your Medical Future
    4. theconversation.com — AI is making journalistic language more repetitive and predictable – and it’s a problem for all of us
    5. www.medscape.com — Can Conversational AI Platforms Free Up Physicians’ Time?
    confidence 75%

  4. Bay Area Lyme Ventures Funds AI Companion for Tick-Borne Disease Management

    LymeLess Health is launching Ella, an AI care companion funded by Bay Area Lyme Ventures to assist patients with Lyme and tick-borne diseases. The tool focuses on helping users manage diagnosis, treatment, and long-term care. This development follows a broader trend of AI integration in specialized medicine, though other reports suggest a shift toward autonomous AI in clinical trials and predictive tools at Harvard Medical School aimed at anticipating symptoms years in advance. These advancements occur as the industry balances automated efficiency with the need for human oversight in life-altering medical decisions.

    Why it matters

    Conversational AI is shifting from general information access to specialized disease management. This transition happens amid ongoing debates over the role of human practitioners in therapy and increasing regulatory scrutiny of AI safety.

    What is confirmed

    • Bay Area Lyme Ventures invested in LymeLess Health to accelerate AI innovation for patients with Lyme and tick-borne diseases.
    • The investment supports the launch of Ella, an AI care companion for diagnosis, treatment, and long-term disease management.

    Still unconfirmed

    • Formstack can create conditional logic forms to replace static questionnaires.

    What to watch next

    • Clinical trial results for autonomous AI screening tools
    • Peer-reviewed data on the efficacy of the Ella AI companion
    • Regulatory responses to AI-driven disease prediction tools
    Sources used for this update (5)
    1. www.manilatimes.net — Bay Area Lyme Ventures Invests in LymeLess Health to Accelerate AI-Powered Innovation for Lyme & Tick-Borne Disease Patients
    2. jen.jiji.com — Do positive affirmations really work? What the evidence shows
    3. www.thetechedvocate.org — Can Formstack create conditional logic forms
    4. www.thetechedvocate.org — This One AI Disease Prediction Tool Just Blew Open the Future of Healthcare
    5. www.thetechedvocate.org — The Shocking Truth About Autonomous AI in Clinical Trials You Need to Know
    confidence 90%

  5. AI Patient Tools Face Operational Hurdles and Regulatory Scrutiny

    Conversational AI is expanding patient access to medical information, but it cannot resolve internal health organization operational problems. While AI transforms how users find mental health data, practitioners argue that lived relational experience remains the primary value of therapy. Simultaneously, AI integration in medicine is advancing through multimodal data in cardiovascular care. These developments coincide with increased regulatory pressure, as a US court recently fined Meta $567 million and mandated reforms for its platforms, including its AI chatbots, citing dangers to children.

    Why it matters

    Medical AI is shifting from administrative tasks to specialized diagnostic tools like the DELFI liver cancer test. This transition creates a tension between AI's tendency to provide likely answers and the medical necessity of identifying rare conditions. Recent court actions against tech giants highlight the safety risks associated with deploying these conversational models to the public.

    What is confirmed

    • A US court fined Meta $567 million and ordered reforms for its platforms and AI chatbots due to online dangers for children.
    • Cardiovascular medicine is integrating longitudinal, high-dimensional, and multimodal data for outcome modelling.

    Still unconfirmed

    • Patient chatbots may improve information access but do not solve operational problems within health organizations.
    • Therapy provides lived, relational experience that AI-driven mental health information cannot replicate.

    What to watch next

    • Implementation of the court-ordered reforms for Meta AI chatbots
    • Clinical trial results for the brain drainage surgery targeting Alzheimer's symptoms
    Sources used for this update (11)
    1. www.forbes.com — Reimagining Healthcare In The Age Of An AI-Empowered Patient
    2. www.newsweek.com — How to Get GLP-1 Weight Loss Drugs for $50: List of Major Pharmacies
    3. www.psychologytoday.com — Why Walk and Talk Therapy Matters More in the Age of AI
    4. www.thetechedvocate.org — Uncovering the Truth: Meta’s $567 Million Fine and What It Means for Your Kids Online
    5. www.thetechedvocate.org — Can ChatGPT write code?
    6. insurancenewsnet.com — The silver economy ushers in a new era of life insurance growth
    7. www.thetechedvocate.org — How to use ChatGPT plugins?
    8. www.frontiersin.org — AI-driven outcome modelling and multimodal data integration in cardiovascular medicine
    9. www.nature.com — A controversial Alzheimer’s surgery is said to reverse symptoms — here’s what scientists know
    10. searchengineland.com — Query templates: Expanding the scope of topical authority
    11. timesofindia.indiatimes.com — Breaking News Live August 12: One killed, 30 injured as pilgrims’ bus overturns in UP’s Lakhimpur Kheri
    confidence 85%

  6. AI Blood Tests and Education Tools Expand Clinical Utility

    Artificial intelligence is moving from administrative support to specialized diagnostic and educational tools. Researchers at the Johns Hopkins Kimmel Cancer Center validated DELFI, an AI-powered blood test that identifies liver cancer, potentially reducing the need for invasive biopsies. In medical education, West Virginia University researchers are testing ChatGPT-5 Pro to generate psychiatry training cases. While AI shows strength in diagnosis, a tension remains between the technology's tendency to converge on likely answers and the medical need to identify rare conditions.

    Why it matters

    These developments follow a trend of AI assisting with clinical decisions and designing new molecules for pulmonary fibrosis. The shift toward non-invasive diagnostics like DELFI addresses the risks associated with traditional gold-standard biopsies. Integrating AI into psychiatric training reflects a broader effort to scale mental health support and education.

    What is confirmed

    • Researchers at the Johns Hopkins Kimmel Cancer Center validated an AI-powered blood test called DELFI to pinpoint liver cancer.
    • West Virginia University researchers used ChatGPT-5 Pro to evaluate its ability to create psychiatry education cases.

    Still unconfirmed

    • AI is effective at diagnosing health problems but less capable than doctors at weighing treatment options.

    What to watch next

    • Clinical adoption rates of the DELFI test compared to traditional liver biopsies.
    • Peer-reviewed results from West Virginia University regarding the accuracy of AI-generated psychiatry cases.
    Sources used for this update (6)
    1. www.psychologytoday.com — Why Every Patient Needs an AI Zebra Scan
    2. www.thetechedvocate.org — NeuroLipoX: The Astonishing Weight Loss Breakthrough of 2026 Reshaping Lives
    3. www.thetechedvocate.org — This Breakthrough AI Blood Test Finds Liver Cancer Earlier — Here’s How
    4. www.thetechedvocate.org — This Game-Changing AI Blood Test Could Replace Painful Liver Biopsies
    5. medicalxpress.com — AI creates psychiatry training cases, but human oversight remains essential
    6. www.wsbradio.com — AI is now very good at diagnosing health problems, but doctors are still better at weighing treatment options
    confidence 85%

  7. AI Expands into Drug Discovery and Clinical Decision Support

    Artificial intelligence is shifting from administrative tasks to direct clinical application. AI now assists doctors with clinical decisions, identifies mental health risks earlier, and extends care via wearables and smartphones. Beyond diagnostics, algorithms are designing new molecules for pulmonary fibrosis that are currently in clinical trials. These advancements occur alongside a new CMS framework for healthcare interoperability, though providers must still meet a baseline interoperability level to participate in the network. This transition aims to connect and interpret vast amounts of healthcare data in real time to improve intelligence.

    Why it matters

    Previous reports focused on consumer-facing health assistants and the limitations of chatbots in mental health. The shift toward drug discovery and clinical decision support represents a move into high-stakes medical intervention. Interoperability standards are necessary to ensure these AI tools can access the data required to function across different health systems.

    What is confirmed

    • AI is helping doctors make clinical decisions and identify mental health risks earlier.
    • AI is expanding healthcare access through smartphones and wearable devices.

    Still unconfirmed

    • The CMS framework allows a gentle opt-in but requires a baseline level of interoperability for network participation.

    What to watch next

    • Clinical trial results for AI-designed pulmonary fibrosis molecules
    • Verification of Alzheimer's early-stage cure claims
    • Implementation data on the CMS interoperability baseline
    Sources used for this update (6)
    1. medcitynews.com — A New Era of Interoperability, But Who Gets Left Behind?
    2. www.thetechedvocate.org — This Breakthrough AI Alzheimer’s Research Just Found a Cure for Early Stages
    3. www.thetechedvocate.org — Unbelievable: AI Just Created a Drug That Could End Pulmonary Fibrosis
    4. news.gatech.edu — From Diagnosis to Wellness, AI's Healthcare Revolution
    5. www.expresshealthcare.in — Ayushman Bharat covers seniors above 70. Are governmental schemes alone enough to secure their care?
    6. www.forbes.com — How Real-Time Interoperability And AI Are Rebuilding Healthcare Intelligence
    confidence 70%

  8. AI Advances in Drug Discovery and Clinical Decision Support

    Artificial intelligence is expanding from administrative tasks to active clinical roles and drug creation. Researchers report that AI now assists doctors with clinical decisions and the early identification of mental health risks. In drug discovery, AI has developed new molecules for pulmonary fibrosis currently in clinical trials. These tools are integrating with smartphones and wearables to broaden healthcare access. Meanwhile, the Centers for Medicare & Medicaid Services has introduced an interoperability framework requiring a baseline standard for network participation to improve real-time data interpretation.

    Why it matters

    The transition to AI-driven care aims to reduce gaps in healthcare access and improve treatment for previously untreatable conditions. This shift relies on the ability of different systems to share and interpret patient data in real time.

    What is confirmed

    • AI helps doctors make clinical decisions and identify mental health risks earlier.
    • AI-designed drugs for pulmonary fibrosis are moving through clinical trials as of July 2026.
    • The CMS interoperability framework requires participants to meet a baseline level of interoperability to join the network.

    Still unconfirmed

    • AI research has found a cure for early stages of Alzheimer's disease.
    • Financial health cover for India's elderly requires support from technology and private insurance.

    What to watch next

    • Clinical trial results for AI-designed pulmonary fibrosis molecules
    • Adoption rates of the CMS interoperability baseline standards
    Sources used for this update (6)
    1. medcitynews.com — A New Era of Interoperability, But Who Gets Left Behind?
    2. www.thetechedvocate.org — This Breakthrough AI Alzheimer’s Research Just Found a Cure for Early Stages
    3. www.thetechedvocate.org — Unbelievable: AI Just Created a Drug That Could End Pulmonary Fibrosis
    4. news.gatech.edu — From Diagnosis to Wellness, AI's Healthcare Revolution
    5. www.expresshealthcare.in — Ayushman Bharat covers seniors above 70. Are governmental schemes alone enough to secure their care?
    6. www.forbes.com — How Real-Time Interoperability And AI Are Rebuilding Healthcare Intelligence
    confidence 80%

  9. Tech Giants Integrate AI Health Assistants Amid Mental Health Limitations

    Samsung has integrated an AI-powered personal health assistant into its Samsung Health platform. However, research indicates AI chatbots still struggle with most mental health conditions. These developments follow earlier reports of AI potential in diagnosis and treatment.

    Still unconfirmed:

    • Samsung released a fully integrated AI-powered personal health assistant within the Samsung Health platform.
    • AI chatbots still struggle with most mental health conditions despite better detection of suicidal ideation.
    Sources used for this update (4)
    1. Medicare For All? Not So Fast.
    2. Samsung Launches AI Health Assistant, Indicating A Growing Trend Among Tech Giants – Forbes
    3. For most mental health conditions, AI remains a liability, research finds
    4. Wellworks For You Releases White Paper Reframing Wellness ROI Around Personalization and Cost Containment
    confidence 70%

  10. Medical AI Agents Show Progress but Lack Clinical Readiness

    Recent studies on agentic AI models indicate potential to assist in diagnosis, treatment, and hospital admissions. Despite these capabilities, these models are not yet prepared for real-world clinical application. Current benchmarks are criticized for lacking actual patient environments.

    What's confirmed:

    • Agentic AI models could assist with patient management stages including diagnosis, treatment, and hospital admission.
    • Neither agentic AI model is ready for real-world clinical use.

    Still unconfirmed:

    • Two medical AIs beat doctors in Nature benchmarks within environments that lacked patients.
    Sources used for this update (4)
    1. Yidu Tech Achieves Its First Full-Year Profit: FY2026 Net Profit Reaches RMB 78.8 Million, with Positive Operating Cash Flow in the Second Half
    2. The Last Mile Problem In Healthcare AI
    3. Agents AMIE and MIRA advance medical AI capabilities - Nature
    4. Nobody fails in the sandbox - by Alex Rivero
    confidence 90%

  11. Google's AMIE AI Shows Potential in Disease Management Simulations

    Google's AMIE system can match or exceed primary care physicians in disease management within simulated environments. A separate real-world trial of a generative AI support tool improved clinical decision-making quality but did not alter short-term patient outcomes. These developments follow recent research published in Nature.

    What's confirmed:

    • Google's AMIE system demonstrates the potential to match or surpass primary care physicians in disease management within simulated environments.
    • Research regarding AMIE was published in the journal Nature.

    Still unconfirmed:

    • AI has surpassed doctors in real EHR processes and multi-round disease management.
    • AI outperforms physicians but not at actual medicine.
    • A generative AI support tool in primary care was safe and improved decision-making quality without changing short-term patient outcomes.
    • Chuck Hemann is the new chief business, AI officer at Assembled Intelligence.
    Sources used for this update (7)
    1. Healthcare comms platform Assembled Intelligence names chief business, AI officer
    2. Clinical trial evaluates generative AI support tool in primary care
    3. [AI Commentary] Google's Medical AI "AMIE" Moves Toward Long-term ...
    4. More Studies Show AI Outperforms Physicians, Just Not at Medicine
    5. Google's AI system achieves clinical management performance comparable ...
    6. Towards Conversational AI for Disease Management - 道客巴巴
    7. 论文速递 2026-06-25 — BioTender
    confidence 80%

  12. Google AMIE and MIRA Match Physician Performance in Nature Study

    Two AI models, Google's AMIE and MIRA, demonstrated the ability to assist with patient management from diagnosis to treatment. Research published in Nature shows these conversational tools perform at least as well as doctors in simulated settings. AMIE is not yet ready for clinical use and requires real-world testing.

    What's confirmed:

    • Research published in Nature on June 17, 2026, presents two AI models, AMIE and MIRA, that can assist with diagnosis and treatment decisions.
    • AMIE and MIRA perform at least as well as physicians in simulated clinical settings.
    • AMIE scored higher than primary care physicians on measures of investigation precision, treatment precision, guideline alignment, and plan appropriateness.
    • AMIE is not ready for clinical use and needs prospective real-world testing.
    Sources used for this update (9)
    1. Two new medical AIs for diagnosis and treatment ... - Medical Xpress
    2. Google's AMIE beats doctors on key simulated disease-management tasks
    3. Google AMIE Matches Doctors in Nature Study · iCharles
    4. AMIE: How Conversational AI Is Moving Beyond Diagnosis to Disease ...
    5. AMIE and MIRA: A Reality Check on the Latest Medical AI Claims
    6. Google's AMIE and MIRA: New AI Models Match Physician Performance in ...
    7. AI medical tools such as Google's 'A… - GIGAZINE（ギガジン）
    8. Trend Analysis: Conversational AI for Disease Management
    9. How AI integration into real-world tasks enhances healthcare and education
    confidence 100%

  13. Google's AMIE AI Matches Doctors in Disease Management Reasoning

    Google Research developed the Articulate Medical Intelligence Explorer (AMIE), an agentic system for multi-visit clinical management. A study published in Nature indicates AMIE is non-inferior to primary care physicians in management reasoning. The system uses Gemini for long-context reasoning to align with clinical guidelines and drug formularies.

    What's confirmed:

    • AMIE was compared to 21 primary care physicians across 100 multi-visit case scenarios in a randomized, blinded virtual OSCE study.
    • Specialists assessed AMIE as non-inferior to primary care physicians in management reasoning.
    • AMIE scored better than physicians in treatment and investigation preciseness and alignment with clinical guidelines.
    • The system utilizes Gemini's long-context capabilities and a two-agent architecture consisting of a Dialogue Agent and a Management Reasoning Agent.
    • A new RxQA benchmark of 600 multiple-choice questions from national drug formularies was used to evaluate medication reasoning.
    • The research was published in Nature on 17 June 2026.

    Still unconfirmed:

    • MIRA integrates with electronic health records to request diagnostic tests and recommend hospital admissions.
    Sources used for this update (13)
    1. Towards autonomous medical artificial intelligence agents
    2. Agentic AI Comes to Medicine
    3. AI medical tools match or surpass doctors for advice
    4. New research shows how AMIE, our medical AI, could help manage health conditions.
    5. Towards Conversational AI for Disease Management
    6. Towards Conversational AI for Disease Management - Nature
    7. Towards Conversational AI for Disease Management - PubMed
    8. Google advances its AMIE research medical AI from diagnosis to treatment
    9. Towards Conversational AI for Disease Management
    10. Articles in 2026 - Nature
    11. Google advances AMIE toward longitudinal disease management
    12. expert reaction to presentation of two new medical AI models for ...
    confidence 100%
📊

Community Sentiment: How do you assess this situation?

Voice your perspective · Real-time aggregated sentiment from the Live Feeds community